Holen Sie sich die Stockscreener-App
134.91
2.10%
2.78
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$132.13
Offen:
$131.65
24-Stunden-Volumen:
1.73M
Relative Volume:
0.99
Marktkapitalisierung:
$20.61B
Einnahmen:
$4.28B
Nettoeinkommen (Verlust:
$1.26B
KGV:
17.09
EPS:
7.8957
Netto-Cashflow:
$943.00M
1W Leistung:
+5.44%
1M Leistung:
+10.84%
6M Leistung:
+53.34%
1J Leistung:
-9.17%
1-Tages-Spanne:
$131.65
$136.24
1-Wochen-Bereich:
$124.27
$136.24
52-Wochen-Spanne:
$68.70
$153.06
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Vergleichen Sie ILMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
134.91 | 20.19B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Stifel reiterates Buy rating on Illumina stock, cites multiple growth levers - Investing.com Australia
Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina
Does Surging Genomics Consumables Demand Reshape The Bull Case For Illumina’s Recurring Revenue Engine (ILMN)? - Yahoo Finance
Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Nasdaq
Precision oncology at your community’s doorstep - Illumina
Illumina Inc ILU Stock Analysis and ForecastAI-Driven Market Analysis & Free Lightning Fast Capital Gains - earlytimes.in
Illumina (ILMN): Assessing Valuation After a Quiet Share Price Rebound - Yahoo Finance
Illumina (NASDAQ:ILMN) Upgraded at Zacks Research - MarketBeat
Illumina at the 2025 China International Import Expo (CIIE) - Illumina
Will Illumina Inc. (ILU) stock draw ESG focused funds2025 Top Decliners & Smart Swing Trading Techniques - Newser
How Illumina Inc. (ILU) stock reacts to fiscal policiesPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - Newser
AI in Biotech Market Is Booming Worldwide | NVIDIA, Illumina - openPR.com
Epigenetics Market size to reach $8.63 Billion by 2035 | Key - openPR.com
American Century Companies Inc. Sells 32,763 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina (ILMN) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
Schroder Investment Management Group Raises Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Will Illumina Inc. (ILU) stock keep high P E multiplesTrade Signal Summary & Safe Capital Allocation Plans - Newser
Can Illumina Inc. (ILU) stock sustain revenue momentumJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Korea Investment CORP Reduces Position in Illumina, Inc. $ILMN - MarketBeat
Why Illumina Inc. (ILU) stock fits value portfoliosOil Prices & Fast Exit/Entry Strategy Plans - Newser
Genetic testing transformed her cancer care—and her family tree - Illumina
Illumina, Inc. $ILMN Stake Lifted by Spyglass Capital Management LLC - MarketBeat
Illumina, Inc.: Financial Data Forecasts Estimates and Expectations | ILMN | US4523271090 - marketscreener.com
Illumina, Inc.: Target Price Consensus and Analysts Recommendations | ILMN | US4523271090 - marketscreener.com
Skandinaviska Enskilda Banken AB publ Buys 6,800 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc.: Revenue and Earnings Analysts Forecasts Revisions | ILMN | US4523271090 - marketscreener.com
State Board of Administration of Florida Retirement System Purchases 2,240 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc.: Dividend historical data and projections - marketscreener.com
Russell Investments Group Ltd. Has $19.79 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
ILMN: Static price chart | Illumina, Inc. | US4523271090 - marketscreener.com
Why global investors buy Illumina Inc. (ILU) stockJuly 2025 Sentiment & Verified Momentum Watchlists - Newser
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Tumor Transcriptomics Research Report 2025: An $8.71 Billion Market by 2030, Driven by Rising Global Cancer Prevalence and Advancements in Genomic Sequencing Technologies - GlobeNewswire Inc.
Prudential Financial Inc. Cuts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Stock Position Lifted by JPMorgan Chase & Co. - MarketBeat
Neuberger Berman Group LLC Purchases 31,438 Shares of Illumina, Inc. $ILMN - MarketBeat
Quadrant Capital Group LLC Buys 17,618 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina’s China Setback Leaves A Discounted Genomics Leader - Finimize
Illumina, Inc. $ILMN Shares Purchased by Coldstream Capital Management Inc. - MarketBeat
Illumina, Inc. Stock (ILMN) Opinions on Strategic Growth and Market Expansion - Quiver Quantitative
Gross margin % of Illumina, Inc. – SIX:ILMN.USD - TradingView
Will Illumina Inc. stock outperform international peersTrade Risk Report & Free Fast Entry Momentum Trade Alerts - BỘ NỘI VỤ
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Illumina Inc. stock undervalued vs historical averagesTrend Reversal & Fast Moving Trade Plans - BỘ NỘI VỤ
DNA Sequencing Market to Hit US$ 51.31 Billion by 2034 at 14.9% - openPR.com
When a worldwide community comes together - Illumina
Rep. Lisa C. McClain Buys Illumina, Inc. (NASDAQ:ILMN) Shares - MarketBeat
Illumina completes $500 million public offering of 4.750% notes due 2030 - Investing.com Nigeria
Illumina completes $500 million public offering of 4.750% notes due 2030 By Investing.com - Investing.com South Africa
Illumina Completes $500M Notes Offering for Expansion - TipRanks
How Will Analyst Reactions to ILMN’s Wolfe Conference Pitch Shape Confidence in Its Turnaround Plan? - simplywall.st
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.52%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):